...from the attached article...DJT is nothing...if not "Flexible"...especially after watching poll numbers plummet...
--------------------
President Donald J. Trump’s second-term health care agenda is taking shape with a clear focus on undoing several Biden-era policies.1 On Inauguration Day, January 20, 2025, Trump signed an executive order reversing initiatives aimed at reducing prescription drug costs for Medicare and Medicaid recipients, expanding the Affordable Care Act (ACA), and increasing protections for Medicaid enrollees. However, experts suggest that the changes may have little immediate impact on out-of-pocket (OOP) health care costs for most Americans.
For instance, one Biden-era initiative overturned by Trump had instructed Medicare to explore ways to reduce drug costs, including a potential $2000 monthly OOP cap on certain generic medications. However, this proposal was still in the early stages of development, and its implementation was uncertain, according to Stacie Dusetzina, PhD, a professor in the Department of Health Policy at Vanderbilt University and board member of The American Journal of Managed Care, who spoke with NBC News.
Key initiatives by former US President Joseph R. Biden, such as the $35 monthly cap on insulin, the $2000 annual OOP cap on Part D prescription drugs for Medicare beneficiaries, and Medicare’s authority to negotiate drug prices under the Inflation Reduction Act, remain unaffected by Trump’s executive actions. However, these moves could hint that the incoming administration may be unwilling to move forward on any of these laid-out policies.
------------------
Link: https://www.ajmc.com/view/trump-reverses-some-biden-drug-pricing-initiatives-potentially-impacting-medicare-costs